Would anyone like to discuss any examples/use cases of SD policy/organizational analyses specific to STEM & DEI business models. (Yes, this is motivated by the new politically-motivated scrutiny in USA.)
We are beginning a search for a research position specific to the the topic of pharmacoequity. I would be happy to let the Director know of your interest as we are focused on applying SDM to the effort.